# Lexeo Therapeutics, Inc.: Form 8-K, filed Apr 7, 2025

- Company: [Lexeo Therapeutics, Inc.](/companies/lxeo.md) (CIK 1907108)
- Form: 8-K
- Filed: 2025-04-07
- Accepted by EDGAR: Apr 7, 2025, 06:06 ET
- Period: 2025-04-07
- Accession: 0000950170-25-051345
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1907108/000095017025051345/lxeo-20250407.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1907108/000095017025051345/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1907108/000095017025051345/lxeo-20250407.htm

Filed Apr 7, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-051345. Last ingested by Listed: Oct 29, 2026, 07:31 ET. No prices; not investment advice.